The Indiana Biosciences Research Institute has named Decio Eizirik as scientific director of the IBRI Diabetes Center. The institute says Eizirik will focus on recruiting early career investigators and defining scientific direction with Administrative Director Robert Considine.
Eizirik will also be involved in the governance of the Lilly DCOE, which is a collaboration with the IU School of Medicine and Eli Lilly and Company where scientists have been researching diabetic complications and related metabolic disorders.
“Many of the innovations in diabetes care have happened here in Indiana,” said Eizirik. “I am eager to grow this team as well as help develop the next generation of innovators in diabetes care. We have an excellent foundation through our research efforts in skeletal muscle and glucose intake, how the brain affects energy expenditure and the relationship between beta cells and the immune system in triggering type 1 diabetes.”
Eizirik has published over 350 papers in peer-reviewed journals and has received several national and international awards, including the 2013 Rumbough Award for outstanding achievements in type 1 diabetes research awarded by the Juvenile Diabetes Research Foundation.